Aliskiren-based versus amlodipine-based antihypertensive treatment in small abdominal aortic aneurysm assessed by FDG-PET

Open-label trial of aliskiren and amlodipine in abdominal aortic aneurysm (AAA) and hypertension (HTN) (2 arms), sponsored by Vrije University Medical Center. Primary endpoints: Change from baseline in aneurysmal FDG uptake after 3 months and Change from baseline in aneurysmal FDG uptake after 12 months. Started Dec 2011; status: active, not recruiting.